North East and North Cumbria
ICS Formulary
ICS Formulary
4 Central nervous system
04-02-02 Antipsychotic depot injections
CNTW
TEWV| Aripiprazole |
|
Formulary
|
Prolonged-release injection
Approved for the treatment of psychosis and schizophrenia in line with NICE guidance
|
 MHRA Drug Safety Update (December 2023): Aripiprazole (Abilify and generic brands): risk of pathological gambling NICE CG178: Psychosis and schizophrenia in adults: prevention and management TEWV Shared Care Guidelines for Aripiprazole |
|
| Paliperidone |
|
Formulary
|
|
|
NICE CG178: Psychosis and schizophrenia in adults: prevention and management TEWV Paliperidone LAI – Shared Care Guidelines |
|
|
CNTW
TEWV
Links
- MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs
- MHRA Drug Safety Update (December 2023): Aripiprazole (Abilify and generic brands): risk of pathological gambling
NENC Palliative and End of Life Care Symptom Control Guidelines- NICE CG103: Delirium
- NICE CG178: Psychosis and schizophrenia in adults: prevention and management
- NICE CG178: Psychosis and schizophrenia in adults: prevention and management
- NICE CG178: Psychosis and schizophrenia in adults: prevention and management
- NICE NG62: Cerebral palsy in under 25s: assessment and management
- TEWV - Medicines Optimisation – Interactive Guide
- TEWV Guidelines
- TEWV Paliperidone LAI – Shared Care Guidelines
- TEWV Safe Transfer of Prescribing Guidance
- TEWV Shared Care Guidelines for Aripiprazole